February 15, 2013
Dr. Diana Bianchi Presents Data Demonstrating Verinata’s Proprietary Technology Detects Genetic Abnormalities in Twin Pregnancies
Study Demonstrates Necessity of Deeper Sequencing in Multiple Gestation Pregnancies
December 3, 2012
Verinata Health’s Non-invasive verifi® Prenatal Test Now Includes Unique Ability to Detect Additional Fetal Chromosomal Abnormalities
verifi® Test Detects Most Common Autosomal and Sex Chromosome Aneuploidies (SCA)
in High-Risk Women
November 9, 2012
Verinata Health Announces New Findings at the American Society of Human Genetics
November 6, 2012
Verinata Health’s verifi® Prenatal Test Expanded To Include The Most Common Sex Chromosome Abnormalities
October 25, 2012
Verinata Health Files Patent Infringement Action Against Ariosa Diagnostics, Inc. and Laboratory Corporation of America Holdings
October 24, 2012
Presentations at the National Society of Genetic Counselors Conference Highlight Verinata Health’s verifi® Prenatal Test
October 3, 2012
Verinata Health, a Leader in Noninvasive Prenatal Testing, Announces Additions to the Senior Management Team
Appoints Vance Vanier, M.D., President; Keith Jones, Ph.D., Senior Vice President of
Research and Development; Suchetta Bhatt, M.D., Vice President of Genetics
July 2, 2012
Verinata Health Expands verifi® Prenatal Test to include Turner Syndrome Option
First Non-Invasive Prenatal Alternative to Detect Monosomy X
May 31, 2012
Verinata Health Announces Successful Introduction of its verifi™ prenatal test
Over 1,100 Tests Ordered in Initial Weeks of Commercial Launch
Two Studies to be Presented at Upcoming International Conference on Prenatal
Diagnosis and Therapy
April 25, 2012
Comprehensive Health Economic Model Demonstrates Clinical Benefit And Cost Effectiveness of Verinata Health’s verifi™ Prenatal Test when Incorporated into Clinical Practice for High-Risk Pregnancies
February 23, 2012
Verinata Announces Peer-Reviewed Manuscript in Obstetrics & Gynecology (The Green Journal), the Official Publication of the American College of Obstetricians and Gynecologists
February 23, 2012
Verinata Health Files Action Against Sequenom to Vindicate Its Rights In the Face of Sequenom’s Threats
February 13, 2012
Verinata Health Announces Presentation and Publication of Top-Line Clinical Validation Study Results for its verifi™ Non-Invasive Prenatal Test
February 10, 2012
Study finds massively parallel sequencing can detect fetal aneuploidies, including Down syndrome
December 7, 2011
Verinata Health Announces New Corporate Headquarters and Expanded Laboratory Operations
October 11, 2011
Verinata Health Adds Holly S. Puritz, MD to Clinical Advisory Board
September 29, 2011
Verinata Health Announces a Multi-Year Supply Agreement With Illumina, Inc.
September 13, 2011
Verinata Health Laboratory Receives Accreditation from College of American Pathologists
September 2, 2011
Verinata Health Announces Issuance of Key Patent for Determination of Fetal Aneuploidy
August 9, 2011
Verinata Health Closing $48.5 Million in Additional Series C Funding
August 9, 2011
Verinata Health Appoints Maternal Fetal Medicine Specialist James D. Goldberg, M.D., to Clinical Advisory Board
July 19, 2011
Verinata Health Announces Leadership Appointments in Sales, Marketing and Bioinformatics. Names Noah Nasser, Vice President, Sales and Market Development; Suzanne Yokota, Vice President Marketing and Commercial Operations and Dr. Xitong Li, Director, Bioinformatics
April 26, 2011
Non-Invasive Prenatal Diagnostic Test Developer Artemis Health, Inc. Changes Name to Verinata Health, Inc. Appoints Industry Veteran Caren L. Mason as Chief Executive Officer
April 26, 2011
Verinata Health Announces Publication of Key Data Reporting Non-Invasive Prenatal Diagnostic Test Potential
View an Archive of our Past News
